Login / Signup

Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study.

Franco LocatelliGerhard ZugmaierNoemi MergenPeter BaderSima JehaPaul-Gerhardt SchlegelJean-Pierre BourquinRupert HandgretingerBenoit BrethonClaudia RossigChristiane Chen-Santel
Published in: Blood cancer journal (2021)
Keyphrases
  • acute lymphoblastic leukemia
  • allogeneic hematopoietic stem cell transplantation
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • multiple myeloma
  • diffuse large b cell lymphoma
  • open label
  • double blind